Pacira Pharmaceuticals reported $34.99M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acelrx Pharmaceuticals ACRX:US $ -9684000 20K
Aerie Pharmaceuticals AERI:US $ -31501000 2.72M
Amerisourcebergen ABC:US $ 847.69M 145.19M
Astellas Pharma 4503:JP 35.8B 59.96B
Bristol Myers Squibb BMY:US $ 2967M 411M
Cara Therapeutics CARA:US $ -30876000 7.32M
Coherus Biosciences CHRS:US $ -24164000 143.2M
Endo International Ordinary Shares ENDP:US $ 195.54M 19.6M
Flexion Therapeutics FLXN:US $ -16882000 6.26M
Heron Therapeutics HRTX:US $ -60469000 8.36M
Horizon Pharma HZNP:US 213.77M 303.22M
Ironwood Pharmaceuticals IRWD:US $ 64.82M 19.22M
JAZZ PHA JAZZ:US -69590000 231.71M
Johnson & Johnson JNJ:US $ 6901M 94M
Lannett LCI:US $ -4934000 7.78M
Ligand Pharmaceuticals LGND:US $ 45.76M 41.04M
Nektar Therapeutics NKTR:US $ -110205000 813K
Omeros OMER:US $ -24016000 6.6M
Pacira Pharmaceuticals PCRX:US $ 34.99M 13.68M
Perrigo Ordinary Shares PRGO:US $ 44.1M 18.3M
Pfizer PFE:US $ 6662M 905M
Revance Therapeutics RVNC:US $ -70337000 325K
Supernus Pharmaceuticals SUPN:US $ 34.11M 20.9M
Teva Pharmaceutical TEVA:IT 829M 35M
Xeris Pharmaceuticals Inc XERS:US $ -25787000 9.05M
Xoma XOMA:US $ -3064000 3.36M
Zoetis ZTS:US $ 726M 33M